BDP9066
BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
348.44
Molecular Formula
C20H24N6
Notes
Research use only, not for human use.
Receptor
ROCK
CAS Number
2226507-04-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS3616937-01 5 mg
1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid
Ask
View Details ![1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid](https://cdn.genprice.uk/genprice/genprice5.png)
MBS3616937-02 10 mg
1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid
Ask
View Details ![1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid](https://cdn.genprice.uk/genprice/genprice2.png)
MBS3616937-03 25 mg
1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid
Ask
View Details MBS3616937-04 50 mg
1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid
Ask
View Details MBS3616937-05 100 mg
1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid
Ask
View Details